FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W226509852> ?p ?o ?g. }

• W226509852 startingPage "369" @default.
• W226509852 abstract "Writing in the December issue of the newsletter of the Drug, Device and Biotech Committee, Michael K. Brown and Thomas J. You of the Los Angeles office of Crosby, Heafey, Roach & May discuss the throwaway defendant: the battle to establish federal court jurisdiction in diversity cases, the fraudulent joinder rule can be a powerful weapon. Plaintiffs, loathe to the rigors and pace of federal court litigation, especially if there is a multidistrict litigation order on the horizon, often will name a local throwaway defendant in order to destroy the complete diversity necessary to remove the case to federal court. the world of pharmaceutical litigation, a familiar strategy by plaintiffs is to target a local pharmacy as the diversity-- destroying pawn to be tossed into the path of the drug manufacturer's removal efforts. Plaintiffs in these circumstances rarely intend in good faith to pursue the local pharmacy. Rather, they usually discard the pharmacy once removal has been deterred. Some plaintiffs will even tip their hand and candidly propose to dismiss the pharmacy in exchange for the drug manufacturer's stipulation to forgo removal. Seeking refuge Drug manufacturers facing this hostage situation can seek some refuge in the rule of fraudulent joinder, which is as stated in Morris v. Princess Cruises Inc., 236 F.3d 1061, 1067 (9th Cir. 2000): [O]ne exception to the requirement of complete diversity is where a non-diverse defendant has been `fraudulently joined.' these cases the court disregards that defendant and recognizes complete Fraudulent joinder exists if the plaintiff fails to state a cause of action against a resident defendant, and the is according to the settled rules of the state. McCabe v. General Foods Corp., 811 F.2d 1336, 1339 (9th Cir. 1987). Though establishing an obvious failure of the claims against a pharmacy can seem to be a daunting task at first glance, drug manufacturers should be aware of how much firepower the fraudulent joinder rule packs. First, the defendant seeking removal is entitled to present the facts showing the joinder to be fraudulent. Morris, the court said: '[F]raudulent joinder claims may be resolved by `piercing the pleadings' and considering summary judgment-- type evidence such as affidavits and deposition testimony.' 236 F.3d at 1068, quoting Cavallini v. State Farm Mutual Auto Insurance Co., 44 F.3d 256, 263 (5th Cir. 1995). Thus, drug manufacturers have far more latitude to make their case than they would in a motion under Rule 12(b)(6) of the Federal Rules of Civil Procedure. Second, courts are cognizant that nondiverse defendants often are named merely for tactical reasons. As the court in Ayoub v. Baggett, 820 F.Supp. 298, 300 (S.D. Tex. 1993) stated: In fact, given the relative financial positions of most companies versus their employees, the only time an employee is going to be sued is when it serves a tactical legal purpose, like defeating diversity. Third, and most important, courts have made good use of the fraudulent joinder rule in numerous pharmaceutical cases. See, e.g., re Rezulin Products Liability Litigation, 133 F.Supp.2d 272, 289 (S.D. N.Y. 2001) (local pharmacies and salespeople held fraudulently joined in prescription drug action against manufacturers); Negrin v. Alza Corp., 1999 WL 144507 at *5 (S.D. N.Y.) (local pharmacy held fraudulently joined in prescription drug case against manufacturer); Strickland v. Brown Morris Pharmacy Inc., 1996 WL 537736 at *2 (E.D. La.) (local pharmacy held fraudulently joined in over-thecounter drug case against manufacturer). See also Johnson v. Parke-Davis, 114 F.Supp.2d 522, 525-26 (S.D. Miss. 2000) (resident sales representatives held fraudulently joined in action against prescription drug manufacturer). Point of vulnerability The key to negating the claims against the local pharmacy lies in the learned intermediary doctrine, the foundation of current drug and medical device products liability law in most jurisdictions. …" @default.
• W226509852 created "2016-06-24" @default.
• W226509852 creator A5026255735 @default.
• W226509852 creator A5028420558 @default.
• W226509852 date "2002-07-01" @default.
• W226509852 modified "2023-09-24" @default.
• W226509852 title "Fraudulent Joinder: Weapon for Federal Court Jurisdiction" @default.
• W226509852 hasPublicationYear "2002" @default.
• W226509852 type Work @default.
• W226509852 sameAs 226509852 @default.
• W226509852 citedByCount "0" @default.
• W226509852 crossrefType "journal-article" @default.
• W226509852 hasAuthorship W226509852A5026255735 @default.
• W226509852 hasAuthorship W226509852A5028420558 @default.
• W226509852 hasConcept C144133560 @default.
• W226509852 hasConcept C17744445 @default.
• W226509852 hasConcept C199539241 @default.
• W226509852 hasConcept C2776949292 @default.
• W226509852 hasConcept C2777134139 @default.
• W226509852 hasConcept C538833194 @default.
• W226509852 hasConcept C97460637 @default.
• W226509852 hasConceptScore W226509852C144133560 @default.
• W226509852 hasConceptScore W226509852C17744445 @default.
• W226509852 hasConceptScore W226509852C199539241 @default.
• W226509852 hasConceptScore W226509852C2776949292 @default.
• W226509852 hasConceptScore W226509852C2777134139 @default.
• W226509852 hasConceptScore W226509852C538833194 @default.
• W226509852 hasConceptScore W226509852C97460637 @default.
• W226509852 hasIssue "3" @default.
• W226509852 hasLocation W2265098521 @default.
• W226509852 hasOpenAccess W226509852 @default.
• W226509852 hasPrimaryLocation W2265098521 @default.
• W226509852 hasRelatedWork W137586339 @default.
• W226509852 hasRelatedWork W1975672492 @default.
• W226509852 hasRelatedWork W2057182297 @default.
• W226509852 hasRelatedWork W2190571489 @default.
• W226509852 hasRelatedWork W223682470 @default.
• W226509852 hasRelatedWork W225719872 @default.
• W226509852 hasRelatedWork W2269699112 @default.
• W226509852 hasRelatedWork W2408247641 @default.
• W226509852 hasRelatedWork W2516086718 @default.
• W226509852 hasRelatedWork W2595049123 @default.
• W226509852 hasRelatedWork W261031583 @default.
• W226509852 hasRelatedWork W282867686 @default.
• W226509852 hasRelatedWork W3163963430 @default.
• W226509852 hasRelatedWork W318023230 @default.
• W226509852 hasRelatedWork W3205772011 @default.
• W226509852 hasRelatedWork W321468547 @default.
• W226509852 hasRelatedWork W324641192 @default.
• W226509852 hasRelatedWork W332996050 @default.
• W226509852 hasRelatedWork W339657975 @default.
• W226509852 hasRelatedWork W2136890069 @default.
• W226509852 hasVolume "69" @default.
• W226509852 isParatext "false" @default.
• W226509852 isRetracted "false" @default.
• W226509852 magId "226509852" @default.
• W226509852 workType "article" @default.